Renal Cortical Necrosis: Prognosis and Evaluation
Renal cortical necrosis (RCN) carries a grave prognosis with progression to end-stage renal disease being the rule in diffuse cortical necrosis, though partial recovery is possible in focal/patchy disease—evaluation should prioritize contrast-enhanced CT or MRI to establish diagnosis and extent, followed by kidney biopsy when feasible to guide prognosis.
Prognosis
The prognosis of RCN is predominantly determined by the extent of cortical involvement:
Diffuse vs. Focal Disease
- Diffuse cortical necrosis: Progression to kidney failure requiring dialysis is essentially inevitable 1, 2, 3
- Partial/focal cortical necrosis: Offers potential for partial renal recovery, with some patients achieving eGFR ≥60 mL/min/1.73 m² 1, 2
- In the most recent case series, only 16% (4/25) of patients showed any renal recovery at discharge, with 84% remaining dialysis-dependent 1
Prognostic Indicators for Poor Outcome
Clinical factors associated with no kidney recovery include 1, 2:
- Persistent anuria beyond the acute phase
- Dialysis dependence at hospital discharge
- Higher schistocyte count at presentation
- Elevated mean arterial pressure at onset
- Elevated lactate dehydrogenase and D-dimer levels during follow-up
Pathologic features predicting poor outcome 2:
- Extensive cortical coagulative necrosis on biopsy
- Glomerular capillary thrombosis
- Pronounced arteriole/artery lesions with intimal edema and fibrin thrombosis
- Interlobular arteriole intimal edema
- Lower occurrence of segmental sclerosis (paradoxically, as this suggests more acute necrosis)
Long-Term Outcomes
At 3-6 months follow-up in recent series 1, 2:
- 41% remained on kidney replacement therapy
- 35% had eGFR 15-60 mL/min/1.73 m²
- 24% achieved eGFR ≥60 mL/min/1.73 m²
However, gradual improvement over years is possible: One case demonstrated successful discontinuation of peritoneal dialysis after 6 months, with sustained kidney function 4 years later (serum creatinine 2.67 mg/dL) 4.
Evaluation Strategy
Initial Diagnostic Approach
When RCN is suspected (postpartum acute kidney injury stage 3, obstetric complications, or sepsis with anuria):
Immediate laboratory assessment:
- Complete blood count (hemoglobin, platelet count, schistocytes)
- Serum creatinine and electrolytes
- Lactate dehydrogenase (LDH)
- Liver enzymes (SGPT, SGOT)
- Coagulation profile including D-dimer
- Urinalysis (typically shows hematuria)
Imaging for diagnosis:
Contrast-enhanced CT or MRI is the diagnostic modality of choice 5, 6, 5:
- CT findings: Loss of cortical enhancement with preserved medullary perfusion 1, 4
- MRI T2-weighted findings 3:
- Diffuse phenotype: Outer cortex swelling in early phase, dark signal rim involving inner cortex and Bertin column, progressive cortical thinning with substantially decreased T2 signal intensity
- Focal phenotype: Focally distributed hypointense signals in cortex
- MRI can be performed without gadolinium contrast using functional sequences (avoiding nephrogenic systemic fibrosis risk) 3
Ultrasound has limited utility 5:
- May show normal-appearing kidneys initially
- Cannot definitively diagnose RCN
- Useful only for excluding obstruction
Timing of Kidney Biopsy
Kidney biopsy should be performed when 1, 2:
- Diagnosis remains uncertain after imaging
- Determining extent of necrosis for prognostic purposes
- Guiding treatment decisions (particularly for atypical hemolytic uremic syndrome)
- Optimal timing: 18 days to 4 months post-delivery (after acute hemolysis resolves)
Key pathologic findings to document 2:
- Extent of cortical necrosis (diffuse vs. patchy)
- Presence of glomerular coagulative necrosis
- Capillary thrombosis
- Arteriole/artery lesions
- Segmental sclerosis patterns (collapsing, cellular, tip, or "not otherwise specified" variants)
- Evidence of thrombotic microangiopathy (present in 52% of cases) 1
Associated Conditions to Evaluate
RCN in obstetric settings is strongly associated with 1, 2, 3:
- Atypical hemolytic uremic syndrome (88% in recent series)
- Postpartum hemorrhage (65%)
- Preeclampsia/HELLP syndrome (41%)
- Disseminated intravascular coagulation (24%)
- Puerperal sepsis
All patients should be evaluated for thrombotic microangiopathy: hemolysis, thrombocytopenia, and elevated liver enzymes are present in virtually all cases at presentation 1.
Follow-Up Evaluation
Serial monitoring during hospitalization:
- Hemoglobin, platelet count, and liver enzymes typically normalize within 12 days 1
- Serum creatinine remains unchanged during this period
- Urine output monitoring for persistent anuria
Long-term follow-up at 3-6 months 1, 2:
- Serum creatinine and eGFR
- LDH and D-dimer (elevated levels predict no recovery)
- Assessment for dialysis independence
- Blood pressure monitoring
Critical Pitfalls
- Do not rely on ultrasound alone—it cannot diagnose RCN and appears normal in early stages 5
- Do not delay imaging when RCN is suspected; early diagnosis with CT/MRI is essential 3, 7
- Do not perform kidney biopsy during acute hemolysis—wait until hematologic parameters stabilize (typically 12 days) 1
- Do not assume recovery is impossible—even with diffuse disease, gradual improvement over months to years can occur in select cases 4
- Recognize that normal hematologic parameters at time of biopsy do not exclude prior thrombotic microangiopathy—the acute phase resolves quickly 1